3056 POSTER XPA, XPD, ERCC1 and XPG/ERCC5 single nucleotide polymorphisme (SNPs) in oxaliplatin-treated colorectal cancer (CRC)

I.Moreno-Solorzano; M.Monzo-Planella; R.Ibeas-Rollan; A.Navarro; R.Artells; B.Gel-Moreno; J.Moreno-Solorzano; R.Hernandez-Borlan; O.Etxaniz; J.Tello

首页> 外文期刊>European Journal of Cancer Supplements >3056 POSTER XPA, XPD, ERCC1 and XPG/ERCC5 single nucleotide polymorphisme (SNPs) in oxaliplatin-treated colorectal cancer (CRC)

【24h】

3056 POSTER XPA, XPD, ERCC1 and XPG/ERCC5 single nucleotide polymorphisme (SNPs) in oxaliplatin-treated colorectal cancer (CRC)

机译：奥沙利铂治疗的结直肠癌（CRC）中的3056 POSTER XPA，XPD，ERCC1和XPG / ERCC5单核苷酸多态性（SNP）

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第4期|共1页
作者
I.Moreno-Solorzano; M.Monzo-Planella; R.Ibeas-Rollan; A.Navarro; R.Artells; B.Gel-Moreno; J.Moreno-Solorzano; R.Hernandez-Borlan; O.Etxaniz; J.Tello;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Predictive Value of Single Nucleotide Polymorphisms of ERCC1 , XPA , XPC , XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine [J] . Radosaw Mlak, Pawe Krawczyk, Iwona Homa-Mlak, Pathology oncology research: POR . 2019,第3期

机译：用顺铂和吉西他滨治疗先进的NSCLC患者中厄尔科，XPA，XPC，XPD和XPG基因的单核苷酸多态性的预测值，参与鼻组机制
2. Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine [J] . Mlak Radoslaw, Krawczyk Pawel, Homa-Mlak Iwona, Pathology oncology research: POR . 2019,第3期

机译：用顺铂和吉西他滨治疗先进的NSCLC患者中厄克二核苷酸，XPA，XPC，XPD和XPG基因的单核苷酸多态性的预测值，涉及先进的NSCLC患者的NER机制
3. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA [J] . LuB., LiJ., GaoQ., Gene: An International Journal Focusing on Gene Cloning and Gene Structure and Function . 2014,第1期

机译：喉癌修复途径基因ERCC1，ERCC2，ERCC3，ERCC4，ERCC5和XPA中的喉癌风险和常见的单核苷酸多态性
4. Reprimo 824 G>C and p53R2 4696 G>C Single Nucleotide Polymorphisms in Healthy, Diverticular Disease and Colorectal Cancer Populations [C] . W. Beasle European Society for Surgical Research . 2005

机译：谴责824g> c和p53r2 4696 g> c健康，憩室疾病和结直肠癌种群中的单核苷酸多态性
5. DNA nucleotide excision repair gene single nucleotide polymorphisms and hereditary nonpolyposis colorectal cancer. [D] . Zhang, Nianxiang. 2007

机译：DNA核苷酸切除修复基因单核苷酸多态性与遗传性非息肉性大肠癌。
6. Predictive Value of Single Nucleotide Polymorphisms of ERCC1 XPA XPC XPD and XPG Genes Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine [O] . Radosław Mlak, Paweł Krawczyk, Iwona Homa-Mlak, -1

机译：顺铂联合吉西他滨治疗晚期NSCLC患者ERCC1XPAXPCXPD和XPG基因的单核苷酸多态性参与NER机制的预测价值
7. Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine [O] . Radosław Mlak, Paweł Krawczyk, Iwona Homa-Mlak, 2018

机译：用顺铂和吉西他滨治疗先进的NSCLC患者中厄尔科，XPA，XPC，XPD和XPG基因的单核苷酸多态性的预测值，参与鼻组机制

3056 POSTER XPA, XPD, ERCC1 and XPG/ERCC5 single nucleotide polymorphisme (SNPs) in oxaliplatin-treated colorectal cancer (CRC)

著录项

相似文献

相关主题

期刊订阅